China Resources Pharmaceutical Group Limited

HKEX:3320.HK

5.58 (HKD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 139,351.412130,461.189138,940.062128,389.889125,716.477122,318.563114,487.606111,035.88189,387.142102,530.908101,922.96195,948.30493,740.80389,794.60682,737.59881,089.6875,615.52375,305.22771,262.87836,642.02633,937.29533,937.29533,937.29533,937.29529,237.67429,237.67429,237.67429,237.674
Cost of Revenue 116,667.377110,594.26116,599.396109,086.81105,884.796104,403.34897,022.53593,608.84274,520.3285,946.80184,489.37877,899.30376,859.42574,046.4370,209.62668,733.69163,862.41363,563.00959,806.23430,842.31128,564.7928,564.7928,564.7928,564.7924,200.40324,200.40324,200.40324,200.403
Gross Profit 22,684.03519,866.92922,340.66619,303.07919,831.68117,915.21517,465.07117,427.03914,866.82216,584.10717,433.58318,049.00116,881.37815,748.17612,527.97212,355.98911,753.1111,742.21811,456.6445,799.7165,372.5065,372.5065,372.5065,372.5065,037.2715,037.2715,037.2715,037.271
Gross Profit Ratio 0.1630.1520.1610.150.1580.1460.1530.1570.1660.1620.1710.1880.180.1750.1510.1520.1550.1560.1610.1580.1580.1580.1580.1580.1720.1720.1720.172
Reseach & Development Expenses 1,017.5381,665.338947.0591,300.199789.319996.133692.418862.787455.177655.325498.968648.714390.566604.252303.924428.119361.297508.269272.875000000000
General & Administrative Expenses 03,742.6993,212.6493,377.572,932.7523,526.532,701.1173,414.9672,148.1852,861.7042,342.0642,563.5762,140.032,423.6371,778.12,138.3751,743.8112,115.2731,729.619961.2231,061.6931,061.6931,061.6931,061.693918.376918.376918.376918.376
Selling & Marketing Expenses 010,382.00310,436.0059,467.9729,077.1839,247.7018,282.9999,259.746,769.70510,274.0598,914.4649,900.4458,440.4358,357.6415,511.1445,979.2314,968.2485,497.4014,614.1452,527.8872,200.0392,200.0392,200.0392,200.0392,105.7792,105.7792,105.7792,105.779
SG&A 14,101.20614,146.7714,358.00313,816.18812,416.57513,080.22311,362.66613,107.9979,397.34813,380.2911,458.38812,553.84410,580.46510,826.627,289.2448,117.6066,712.0597,612.6746,343.7643,489.113,261.7323,261.7323,261.7323,261.7323,024.1553,024.1553,024.1553,024.155
Other Expenses 00000000000000000-3,689.7-3,148.32-3,148.32-3,040.221-3,040.221-3,040.221-3,040.221-2,912.776-2,912.776-2,912.776-2,912.776
Operating Expenses 15,118.74415,496.90615,305.06215,116.38713,205.89414,076.35612,055.08413,970.7849,852.52514,035.61511,957.35612,776.69510,492.89410,653.0087,224.497,604.2256,704.2227,729.7035,558.071340.789221.511221.511221.511221.511111.38111.38111.38111.38
Operating Income 7,565.2924,252.7957,035.6044,186.6926,625.7873,838.8595,409.9873,456.2555,014.2972,548.4925,476.2274,787.5275,656.6934,389.8054,897.693,834.84,488.1323,170.0654,709.2021,717.151,552.861,552.861,552.861,552.861,467.1341,467.1341,467.1341,467.134
Operating Income Ratio 0.0540.0330.0510.0330.0530.0310.0470.0310.0560.0250.0540.050.060.0490.0590.0470.0590.0420.0660.0470.0460.0460.0460.0460.050.050.050.05
Total Other Income Expenses Net -145.388-490.114-159.245-1,114.826-230.584-767.316-386.695-1,001.869-600.027-1,789.846264.278-715.512-546.231-227.424-477.723-20.909-259.358-212.276383.304295.424177.833177.833177.833177.833261.094261.094261.094261.094
Income Before Tax 7,419.9043,762.6816,876.3593,071.8666,395.2033,071.5435,023.2922,454.3864,414.27758.6465,740.5054,072.0155,110.4624,162.3814,419.9673,813.8914,228.7742,957.7895,092.5062,012.5741,730.6931,730.6931,730.6931,730.6931,728.2281,728.2281,728.2281,728.228
Income Before Tax Ratio 0.0530.0290.0490.0240.0510.0250.0440.0220.0490.0070.0560.0420.0550.0460.0530.0470.0560.0390.0710.0550.0510.0510.0510.0510.0590.0590.0590.059
Income Tax Expense 1,631.417894.3391,423.679599.6371,412.765689.5071,071.519910.039841.828416.9541,124.811562.4741,047.679748.646966.8361,026.3121,048.264737.1751,230.886492.015357.726357.726357.726357.726364.572364.572364.572364.572
Net Income 2,822.631,206.3723,038.061,122.3663,025.0461,330.7832,438.106719.9322,577.194251.0493,035.371,727.9762,249.6271,672.5891,810.4471,185.3411,636.069568.4122,281.6641,520.5591,372.9681,372.9681,372.9681,372.9681,363.6571,363.6571,363.6571,363.657
Net Income Ratio 0.020.0090.0220.0090.0240.0110.0210.0060.0290.0020.030.0180.0240.0190.0220.0150.0220.0080.0320.0410.040.040.040.040.0470.0470.0470.047
EPS 0.450.190.480.180.480.210.390.110.410.040.480.270.360.270.290.230.350.120.490.250.220.220.220.220.220.220.220.22
EPS Diluted 0.450.190.480.180.480.210.390.110.410.040.480.270.360.270.290.230.350.120.490.250.220.220.220.220.220.220.220.22
EBITDA 9,329.4535,696.8148,751.2995,736.0278,228.6025,295.7286,775.0084,696.8876,217.7183,788.7546,600.8125,526.9446,434.6795,052.8415,686.3694,342.3985,163.4433,848.0065,298.7312,053.6121,891.0611,891.0611,891.0611,891.0611,766.0591,766.0591,766.0591,766.059
EBITDA Ratio 0.0670.0440.0630.0450.0650.0430.0590.0420.070.0370.0650.0580.0690.0560.0690.0540.0680.0510.0740.0560.0560.0560.0560.0560.060.060.060.06